Allele Biotechnology Overview
- Year Founded
-
1999
- Status
-
Private
- Employees
-
29
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$450K
- Investors
-
8
Allele Biotechnology General Information
Description
Developer of cell therapy and regenerative medicine technologies designed to support therapeutic development through cellular reprogramming. The company's platform offers non-integrating cellular reprogramming methods, good manufacturing practice-induced pluripotent stem cell lines, nanobody development, and fluorescent protein technologies, enabling biotechnology companies, pharmaceutical companies, and research institutions to advance cell therapy research and therapeutic development.
Contact Information
Website
allelebiotech.comCorporate Office
- 6404 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Corporate Office
- 6404 Nancy Ridge Drive
- San Diego, CA 92121
- United States
Allele Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 01-Sep-2018 | $450K | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series A1) | 26-Oct-2016 | Completed | Generating Revenue | |||
| 7. Grant | 14-Sep-2016 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jan-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 24-Sep-2014 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2013 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jan-2010 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2003 | $199K | Completed | Pre-Clinical Trials | ||
| 1. Grant | 01-Jan-2001 | $449K | Completed | Pre-Clinical Trials |
Allele Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
Allele Biotechnology Comparisons
Industry
Financing
Details
Allele Biotechnology Competitors (29)
One of Allele Biotechnology’s 29 competitors is GeneTex, a Formerly VC-backed company based in Irvine, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GeneTex | Formerly VC-backed | Irvine, CA | ||||
| Allele Life Sciences Private | Corporation | Noida, India | ||||
| New England Biolabs | Corporation | Ipswich, MA | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| Molecular Express | Corporation | Los Angeles, CA |
Allele Biotechnology Patents
Allele Biotechnology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2019170405-A | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna | Pending | 22-Jul-2019 | ||
| JP-2024164090-A | Method of achieving high specificity of gene editing | Pending | 13-Jul-2018 | ||
| CA-3106162-A1 | Methods of achieving high specificity of genome editing | Pending | 13-Jul-2018 | ||
| EP-3820503-A1 | Methods of achieving high specificity of genome editing | Pending | 13-Jul-2018 | ||
| EP-3820503-A4 | Methods of achieving high specificity of genome editing | Pending | 13-Jul-2018 | C12N15/102 |
Allele Biotechnology Signals
Allele Biotechnology Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| TriAnchor Capital Group | PE/Buyout | Minority | ||
| National Institute of General Medical Sciences | Government | |||
| National Institute on Aging | Government | |||
| Tsing-Yuan Capital | Venture Capital | Minority | ||
| Yifang Technology Group | Venture Capital | Minority |
Allele Biotechnology FAQs
-
When was Allele Biotechnology founded?
Allele Biotechnology was founded in 1999.
-
Where is Allele Biotechnology headquartered?
Allele Biotechnology is headquartered in San Diego, CA.
-
What is the size of Allele Biotechnology?
Allele Biotechnology has 29 total employees.
-
What industry is Allele Biotechnology in?
Allele Biotechnology’s primary industry is Biotechnology.
-
Is Allele Biotechnology a private or public company?
Allele Biotechnology is a Private company.
-
What is Allele Biotechnology’s current revenue?
The current revenue for Allele Biotechnology is .
-
How much funding has Allele Biotechnology raised over time?
Allele Biotechnology has raised $18M.
-
Who are Allele Biotechnology’s investors?
TriAnchor Capital Group, National Institute of General Medical Sciences, National Institute on Aging, Tsing-Yuan Capital, and Yifang Technology Group are 5 of 8 investors who have invested in Allele Biotechnology.
-
Who are Allele Biotechnology’s competitors?
GeneTex, Allele Life Sciences Private, New England Biolabs, Abcam, and Molecular Express are some of the 29 competitors of Allele Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process